Acceleration of the expansion process of China Resources North Medicine，Competition for Chinese pharmaceutical business for big shows and heat, add salary firewood。

A few days ago，China Resources announced in Suzhou，Signed a cooperation agreement with the local pharmaceutical business leader Suzhou Li'an Pharmaceutical Co., Ltd. (hereinafter referred to as "Suzhou Li'an")，Injects 1 billion yuan from China Resources's Beijing Pharmaceutical Co., Ltd. (hereinafter referred to as "North Medical Co., Ltd.")，Holding 65 % stake in Suzhou Li'an。At the same time，Bei Medical Co., Ltd. will be supported by the Suzhou Municipal Government and the High -tech Zone，Build a large modern pharmaceutical logistics distribution center。

　　

Mou in the south

April this year，China stake sports betting appResources My stake betting appofficially incorporates Beiyi shares into its under all，This also means that the North Medical Shares of the Northern Circulation Giant will no longer be safe。According to the "Central City Construction Platform，Secondary Urban Construction Network "strategy，Beiyi shares in just a few months，Pack from north to south，Realize the Northeast、Shandong、Inner Mongolia、Henan、Hebei、Zhejiang、Jiangsu's layout。

The acquisition of Suzhou Li'an this time，Regardless of whether it is from China Resources North Medicine itself，Still the entire industry，All have special significance。"This means that we finally crossed the Yangtze River。Let's cooperate with Suzhou Li'an is a strong union，Li'an will be our development platform in the southeast，Expand to the surrounding areas，We plan to achieve a scale of more than 10 billion in Southern Jiangsu in three years。"Cheng Jun, deputy general manager of Bei Medical Co., Ltd. told the reporter of" Medical Economic News "。

For choosing Suzhou Li'an，Beiyi shares are quite satisfied。It is understood，Suzhou Li'an is the largest pharmaceutical business company in Suzhou，The current sales scale reaches 4.3 billion yuan。

"This merger should have an iconic significance for Huarun North Medicine，Break through the south of the Yangtze River，Directly forced Chinese medicine、The hinterland of the new medicine，Perform personal melee。"Guo Fanli, a researcher at the pharmaceutical industry in the China Investment Consultant Pharmaceutical Industry。

In national medicine、The new medicine in the past two years is under the background，China Resources stake betting appstake online sports bettingNorth Medicine has been slightly passive。At this time, acceleration, especially the layout of the East China region, it is very necessary and urgent。Dested，Before winning Suzhou Li'an，China Resources North Medicine has just "swallowed" Shandong circulating giant Jinan CITIC Pharmaceutical Co., Ltd.，Complete the layout of Shandong，and "Plan for integration in Shandong，Achieve over 10 billion yuan within two years "。

This mode will continue to be copied，Hunan、Hubei、Guangdong and Guangxi and Jiangxi、Sichuan、Chongqing and other places have been determined to be the target province of China Resources North Medicine。According to statistics，At present, the total operating scale of China Resources North Pharmaceutical's medical circulation enterprises is 47.56 billion yuan，Among them, 8 companies are located in the top 100 medical circulation。

Chairman of the North Medical Co., Ltd. Chen Jisheng said in the internal meeting of the "Discussion on the Development Strategy of China Resources North Medicine Circulation Plate":，Integrated internal and external commodity resources，Relying on quick、High -quality、Smart customer service，Comprehensive supply chain management，Return to control market channels、The purpose of improving the market share，It reflects business value in all marketing activities，to achieve the strategic goal of creating a medical platform for central enterprises，Become a leading company in China's pharmaceutical circulation industry。

　　

Speed ​​up for local resources

"The nearly three years are the critical period of the development of the circulation industry，stake sports betting appstake sports betting appDevelopment must be accelerated。"Cheng Jun said。

"From the perspective of policy guidance，For Chinese medicine、New medicine、China Resources Groups are very favorable。‘Twelfth Five -Year Plan 'period The focus of the medical circulation field is to encourage drug distribution enterprises to merge and reorganize，Cultivate national level、Local -level leading aircraft carrier enterprises。"" In Guo Fanli's view，The opportunities faced by these "national" troops will be more challenging and have their own advantages，The key depends on the implementation of each specific strategy。

"Now is the expansion stage，To quickly make the plate bigger，Not necessarily mergers and acquisitions are excellent assets。"Guo Fanli said。

In this context，M & A in the field of pharmaceutical circulation will undoubtedly usher in a new peak。"Under the southern South platform of Li'an，Maybe there may be 7 or eight local companies to join。"" Cheng Jun revealed。Obviously，The competition of several major groups on local high -quality assets will also become more white and heat。Some people said，Previous medicine、New medicine has negotiated with Suzhou Li'an。Dested，In the unprecedented integration tide of medical circulation，The fate of private pharmaceutical business will inevitably change。

"Private commercial enterprises are facing choices，Now I need to speed up choice，The earlier the choice, the more favorable。"Cheng Jun said。

For China Resources North Pharmaceutical and State Control, the upcoming "Portable Bats"，Cheng Jun said: "The competition between our two parties，will jointly speed up stake online sports bettingstake online sports bettingindustry integration。"and his current task，It was before the end of this year，Complete China Resources stake betting appstake online sports bettingNorth Medicine has been officially listed、Reorganization of a number of companies signed an agreement and a cooperation framework agreement。